Market Cap 18.64B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 28.12
Forward PE 26.05
Profit Margin -27.97%
Debt to Equity Ratio 0.42
Volume 1,058,732
Avg Vol 1,775,370
Day's Range N/A - N/A
Shares Out 152.80M
Stochastic %K 80%
Beta 1.42
Analysts Sell
Price Target $116.20

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
ACE52WeekHigh
ACE52WeekHigh Nov. 14 at 8:12 PM
0 · Reply
tievLeaf
tievLeaf Nov. 14 at 11:01 AM
$CDTX the next one is $QSI. the buyout is likely $ILMN or $TMO. Go read around online.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:34 AM
$ILMN: The stock closed at $119.93, approaching the 60-day high of $126.0, indicating a potential resistance level. The RSI at 68.99 suggests that the stock is nearing overbought territory, which may limit upside potential in the short term. The 30-day moving average (MA30) at $105.28 and the 50-day moving average (MA50) at $102.4 indicate a strong bullish trend, as the current price is significantly above these averages. Directional bias is cautiously bullish, but the high RSI and proximity to the 60D high warrant caution. Suggested entry: $118.50 on a pullback. Stop loss: $113.00 to manage risk. Targets: $125.00 (first target) and $128.50 (second target) if momentum continues. Monitor for signs of reversal as the price approaches resistance. https://privateprofiteers.com
0 · Reply
SqueezedGains
SqueezedGains Nov. 13 at 11:54 PM
0 · Reply
Mrstock2255
Mrstock2255 Nov. 13 at 10:38 PM
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:40 AM
$ILMN: The stock closed at $123.31, indicating a strong position above the 30-day moving average (MA30) of $103.96 and the 50-day moving average (MA50) of $101.45. The RSI at 74.56 suggests that the stock is overbought, indicating potential for a pullback. The recent 60-day high of $126.00 presents a resistance level, while the low of $88.00 indicates a significant support range. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high, which may lead to profit-taking. Suggested entry: $121.50 (on a pullback). Stop: $118.00 (below recent support). Targets: $126.00 (first target at the 60D high) and $130.00 (second target if momentum resumes). Monitor for changes in momentum and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:17 AM
$ILMN: The stock closed at $123.31, indicating a strong position above the 30-day moving average (MA30) of $103.96 and the 50-day moving average (MA50) of $101.45. The RSI at 74.56 suggests that the stock is overbought, indicating potential for a pullback. The recent 60-day high of $126.00 presents a resistance level, while the low of $88.00 indicates a significant support range. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high, which may lead to profit-taking. Suggested entry: $121.50 (on a pullback). Stop: $118.00 (below recent support). Targets: $126.00 (first target at the 60D high) and $130.00 (second target if momentum resumes). Monitor for changes in momentum and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
HarveyToronto
HarveyToronto Nov. 11 at 2:26 AM
$ILMN don't forget that ILMN is among the few who has monopoly in the world. $GOOGL $TSM
0 · Reply
mstan
mstan Nov. 10 at 2:45 PM
$ILMN https://www.streetinsider.com/dr/news.php?id=25581762
0 · Reply
CapitalGains007
CapitalGains007 Nov. 9 at 4:38 PM
$GRAL $ILMN you think ILMN’s $10B failed acquisition then illegal acquisition somehow makes GRAIL a good investment? Read the suit haha. Again, you don’t know what you’re talking about fundamentally.
0 · Reply
Latest News on ILMN
Illumina To Webcast Upcoming Investor Conference

Nov 11, 2025, 4:05 PM EST - 3 days ago

Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 PM EDT - 14 days ago

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript


ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 7 weeks ago

ILMN Stock vs. IQV Stock

IQV


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL IONS MRNA RGEN


Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 3 months ago

Illumina: The Stock Is Still Undervalued


Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 3 months ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript


Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 4 months ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away


Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 6 months ago

Illumina Analysts Lower Their Forecasts After Q1 Results


Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 6 months ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025


Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 6 months ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript


Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Mar 27, 2025, 8:35 AM EDT - 8 months ago

Is Illumina Undervalued After An 83% Drop In Its Stock Price?


Activist Investor Meister to Join Illumina's Board

Mar 25, 2025, 8:00 AM EDT - 8 months ago

Activist Investor Meister to Join Illumina's Board


ACE52WeekHigh
ACE52WeekHigh Nov. 14 at 8:12 PM
0 · Reply
tievLeaf
tievLeaf Nov. 14 at 11:01 AM
$CDTX the next one is $QSI. the buyout is likely $ILMN or $TMO. Go read around online.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:34 AM
$ILMN: The stock closed at $119.93, approaching the 60-day high of $126.0, indicating a potential resistance level. The RSI at 68.99 suggests that the stock is nearing overbought territory, which may limit upside potential in the short term. The 30-day moving average (MA30) at $105.28 and the 50-day moving average (MA50) at $102.4 indicate a strong bullish trend, as the current price is significantly above these averages. Directional bias is cautiously bullish, but the high RSI and proximity to the 60D high warrant caution. Suggested entry: $118.50 on a pullback. Stop loss: $113.00 to manage risk. Targets: $125.00 (first target) and $128.50 (second target) if momentum continues. Monitor for signs of reversal as the price approaches resistance. https://privateprofiteers.com
0 · Reply
SqueezedGains
SqueezedGains Nov. 13 at 11:54 PM
0 · Reply
Mrstock2255
Mrstock2255 Nov. 13 at 10:38 PM
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:40 AM
$ILMN: The stock closed at $123.31, indicating a strong position above the 30-day moving average (MA30) of $103.96 and the 50-day moving average (MA50) of $101.45. The RSI at 74.56 suggests that the stock is overbought, indicating potential for a pullback. The recent 60-day high of $126.00 presents a resistance level, while the low of $88.00 indicates a significant support range. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high, which may lead to profit-taking. Suggested entry: $121.50 (on a pullback). Stop: $118.00 (below recent support). Targets: $126.00 (first target at the 60D high) and $130.00 (second target if momentum resumes). Monitor for changes in momentum and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:17 AM
$ILMN: The stock closed at $123.31, indicating a strong position above the 30-day moving average (MA30) of $103.96 and the 50-day moving average (MA50) of $101.45. The RSI at 74.56 suggests that the stock is overbought, indicating potential for a pullback. The recent 60-day high of $126.00 presents a resistance level, while the low of $88.00 indicates a significant support range. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high, which may lead to profit-taking. Suggested entry: $121.50 (on a pullback). Stop: $118.00 (below recent support). Targets: $126.00 (first target at the 60D high) and $130.00 (second target if momentum resumes). Monitor for changes in momentum and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
HarveyToronto
HarveyToronto Nov. 11 at 2:26 AM
$ILMN don't forget that ILMN is among the few who has monopoly in the world. $GOOGL $TSM
0 · Reply
mstan
mstan Nov. 10 at 2:45 PM
$ILMN https://www.streetinsider.com/dr/news.php?id=25581762
0 · Reply
CapitalGains007
CapitalGains007 Nov. 9 at 4:38 PM
$GRAL $ILMN you think ILMN’s $10B failed acquisition then illegal acquisition somehow makes GRAIL a good investment? Read the suit haha. Again, you don’t know what you’re talking about fundamentally.
0 · Reply
NumbersTalk
NumbersTalk Nov. 7 at 3:21 PM
$ILMN We ever getting back to 500 chat?
1 · Reply
tievLeaf
tievLeaf Nov. 6 at 3:26 PM
$QSI for everyone still here. I know everyone believe in the company but i hope everyone sees this message. The reason why genome sequencing got so big was because of the human genome project (HGP) which was super ambitious and was completed in around 2003. That was effectively a project that moonshot genome sequencing to the multi-billion industry it is today. In our case, we do have one too. It is called the human proteome project (HPP) in short. Here are the details below in image format. we are at 93.01% and if you are truly here for the long term, just know that when this hits 100%, we will be seeing the rise of a company equal to the likes of $ILMN. "Illumina's significant growth was accelerated and amplified by the demand for large-scale, low-cost DNA sequencing that immediately followed the completion of the Human Genome Project (HGP)" Quoted. I am placing my bets on $QSI being one of the big ones to capitalize on this. I hope everyone can see the bigger vision. $RXRX $QBTS
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 5 at 10:49 PM
0 · Reply
HarveyToronto
HarveyToronto Nov. 5 at 10:28 PM
0 · Reply
HarveyToronto
HarveyToronto Nov. 5 at 9:01 PM
$ILMN was trading around $135 before the China ban. Now that the ban has been withdrawn, I expect the market to reprice this to 135 again.
0 · Reply
Drew5896
Drew5896 Nov. 5 at 5:47 PM
$ILMN got some Dec $110 and 140s
0 · Reply
GPS_hawkeye
GPS_hawkeye Nov. 5 at 5:24 PM
$FOXO listen as you read lyrics below https://www.youtube.com/watch?v=HyWajWueH2w ​partners take note $RNVA $ILMN (well, ILMN was a partner and made lawsuit against FOXO, what does that sya about Foxo??)
0 · Reply
Menge
Menge Nov. 5 at 4:09 PM
0 · Reply
HarveyToronto
HarveyToronto Nov. 5 at 2:27 PM
$ILMN 135 is coming. Hours later, the Commerce Ministry said it would remove 15 American firms from an export control list, while taking 10 other US companies off its unreliable entity list. Beijing will also scrap a ban on Illumina Inc.’s exports of its DNA sequencer to China.
0 · Reply
LadyBABA
LadyBABA Nov. 3 at 11:57 PM
0 · Reply
Menge
Menge Nov. 3 at 9:53 AM
0 · Reply
Eddyg987
Eddyg987 Nov. 2 at 3:24 AM
$ILMN can we get a pull back I sold too early
0 · Reply